Edition:
United States

Omeros Corp (OMER.OQ)

OMER.OQ on NASDAQ Stock Exchange Global Market

15.84USD
25 May 2017
Change (% chg)

$-0.25 (-1.55%)
Prev Close
$16.09
Open
$16.18
Day's High
$16.42
Day's Low
$15.78
Volume
82,874
Avg. Vol
129,028
52-wk High
$17.19
52-wk Low
$7.20

Select another date:

Wed, May 17 2017

BRIEF-Omeros completes IGA nephropathy cohort in OMS721 phase 2 clinical trial

* Omeros announces completion of IGA nephropathy cohort in OMS721 phase 2 clinical trial

BRIEF-Omeros reports Q1 revenue $12.3 million

* Omeros Corporation reports first quarter 2017 financial results

BRIEF-Omeros reports more positive data in OMS721 phase 2 trial in renal diseases

* Omeros reports more positive data in OMS721 phase 2 trial in renal diseases

BRIEF-Omeros reports additional positive results from OMS721 Phase 2 trial

* Omeros reports additional positive results from OMS721 phase 2 trial in patients with stem cell transplant-associated thrombotic microangiopathy

Select another date:

More From Around the Web